您的位置: 首页 > 农业专利 > 详情页

HETEROCYCLES CAPABLE OF MODULATING T-CELL RESPONSES, AND METHODS OF USING SAME
专利权人:
Nogra Pharma Limited
发明人:
Daan Hommes,Auke Verhaar,Gijs Van den Brink,Francesca Viti
申请号:
US16229687
公开号:
US20190367480A1
申请日:
2018.12.21
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present disclosure is directed in part to heterocycles, and their use in treating medical disorders, such as immune inflammatory disorders such as Crohn's disease, ulcerative colitis, rheumatic disorders, psoriasis, and allergies. The compounds are contemplated to modulate T-Cell responses.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充